Eli Lilly (NYSE: LLY) EVP awarded 4,383.734 company shares at $1,044.67

Rhea-AI Filing Summary

Eli Lilly executive Edgardo Hernandez reported an equity award of company stock. On 02/09/2026, he acquired 4,383.734 shares of Eli Lilly common stock in a grant or award at $1,044.67 per share. Following this award, he directly holds 46,095.717 shares and indirectly holds 871.35 shares through a 401(k) plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hernandez Edgardo

(Last) (First) (Middle)

LILLY CORPORATE CENTER

(Street)

INDIANAPOLIS IN 46285

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ELI LILLY & Co [ LLY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Pres., Mfg. Operations

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		A		4,383.734	A	$1,044.67	46,095.717	D
Common Stock								871.35	I	401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Jonathan Groff for Edgardo Hernandez, pursuant to authorization on file	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Edgardo Hernandez report at Eli Lilly (LLY)?

Edgardo Hernandez reported an acquisition of Eli Lilly common stock through a grant or award. On 02/09/2026, he received 4,383.734 shares at $1,044.67 per share, as shown in the non-derivative securities table for this Form 4 filing.

How many Eli Lilly (LLY) shares does Edgardo Hernandez own after this transaction?

After the reported grant, Edgardo Hernandez directly owns 46,095.717 Eli Lilly common shares. He also has an additional 871.35 shares held indirectly through a 401(k) plan, according to the beneficial ownership figures in the Form 4 tables.

Was Edgardo Hernandez’s Eli Lilly (LLY) transaction an open-market purchase?

The transaction is reported with code A, described as a grant, award, or other acquisition, not an open-market purchase. The shares were acquired at a stated price of $1,044.67 per share as part of an equity award arrangement.

What indirect Eli Lilly (LLY) holdings does Edgardo Hernandez report?

In addition to his direct holdings, Edgardo Hernandez reports indirect ownership of 871.35 Eli Lilly common shares. These shares are held through a 401(k) plan, as indicated by the indirect ownership code I and the nature of ownership description "401(k)".

What is Edgardo Hernandez’s role at Eli Lilly (LLY) in this Form 4?

Edgardo Hernandez is identified as an officer of Eli Lilly, serving as EVP & Pres., Mfg. Operations. His position is disclosed in the relationship section of the Form 4, which also clarifies he is not listed as a director or 10% owner.

What does transaction code A mean in this Eli Lilly (LLY) Form 4?

Transaction code A in this Form 4 is described as a grant, award, or other acquisition of securities. Here it indicates that 4,383.734 Eli Lilly common shares were awarded to Edgardo Hernandez on 02/09/2026 rather than bought on the open market.